Vimta Labs (BOM:524394) Cyclically Adjusted Revenue per Share: ₹71.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524394 Vimta Labs Ltd BOM:524394
84 GF Score
Price ₹617.60
GF Value ₹511.79
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Vimta Labs Cyclically Adjusted Revenue per Share?

Vimta Labs BOM:524394 +0.17% 84 Cyclically Adjusted Revenue per Share is ₹71.25 as of Jun. 2026. GuruFocus rates BOM:524394 with a GF Score™ of 84/100 and a GF Value™ of ₹511.79 (Modestly Overvalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vimta Labs's adjusted revenue per share for the three months ended in Jun. 2026 was ₹24.155. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹71.25 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Vimta Labs's average Cyclically Adjusted Revenue Growth Rate was 11.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vimta Labs was 10.20% per year. The lowest was 9.60% per year. And the median was 9.60% per year.

As of today (2026-08-31), Vimta Labs's current stock price is ₹617.60. Vimta Labs's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹71.25. Vimta Labs's Cyclically Adjusted PS Ratio of today is 8.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vimta Labs was 13.73. The lowest was 1.05. And the median was 4.20.


Vimta Labs  (BOM:524394) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vimta Labs's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=617.60/71.25
=8.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vimta Labs was 13.73. The lowest was 1.05. And the median was 4.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vimta Labs Cyclically Adjusted Revenue per Share Related Terms


Vimta Labs Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Vimta Labs's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimta Labs Cyclically Adjusted Revenue per Share Chart

Vimta Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.88 52.32 56.32 61.64 68.87

Vimta Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.66 65.72 67.27 68.87 71.25

BOM:524394 vs TMO, DHR, NTRA: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Vimta Labs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimta Labs Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimta Labs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vimta Labs's Cyclically Adjusted PS Ratio falls into.


BOM:524394
84GF Score
Vimta Labs Ltd BOM:524394
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimta Labs Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vimta Labs's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=24.155/167.3573*167.3573
=24.155

Current CPI (Jun. 2026) = 167.3573.

Vimta Labs Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 8.546 105.961 13.498
201612 8.694 105.196 13.831
201703 9.187 105.196 14.616
201706 8.736 107.109 13.650
201709 9.884 109.021 15.173
201712 10.500 109.404 16.062
201803 11.737 109.786 17.892
201806 12.330 111.317 18.537
201809 12.168 115.142 17.686
201812 11.490 115.142 16.701
201903 11.050 118.202 15.645
201906 9.976 120.880 13.812
201909 9.638 123.175 13.095
201912 11.636 126.235 15.427
202003 9.257 124.705 12.423
202006 7.423 127.000 9.782
202009 13.433 130.118 17.277
202012 13.271 130.889 16.969
202103 13.058 131.771 16.585
202106 13.875 134.084 17.318
202109 16.697 135.847 20.570
202112 14.901 138.161 18.050
202203 16.029 138.822 19.324
202206 17.553 142.347 20.637
202209 18.052 144.661 20.884
202212 17.039 145.763 19.563
202303 17.502 146.865 19.944
202306 18.479 150.280 20.579
202309 11.439 151.492 12.637
202312 16.562 152.924 18.125
202403 16.249 153.035 17.770
202406 16.645 155.789 17.881
202409 18.786 157.882 19.913
202412 19.996 158.323 21.137
202503 20.828 157.552 22.124
202506 21.739 159.755 22.773
202509 22.701 162.289 23.410
202512 22.098 163.281 22.650
202603 23.905 164.272 24.354
202606 24.155 167.357 24.155

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹71.25 mean?
Vimta Labs (BOM:524394) has a Cyclically Adjusted Revenue per Share of ₹71.25 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vimta Labs and its competitors.
Is Vimta Labs' Cyclically Adjusted Revenue per Share too high?
Vimta Labs' current Cyclically Adjusted Revenue per Share is ₹71.25. Overall, Vimta Labs has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vimta Labs' Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Vimta Labs' Cyclically Adjusted Revenue per Share of ₹71.25 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vimta Labs and its competitors. Vimta Labs's current Cyclically Adjusted Revenue per Share is ₹71.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimta Labs stock overvalued right now?
Based on GuruFocus' analysis, Vimta Labs (BOM:524394) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹511.79, compared to a current price of ₹617.60 — trading 20.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹71.25. Vimta Labs' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Vimta Labs (BOM:524394), the current Cyclically Adjusted Revenue per Share is ₹71.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimta Labs (BOM:524394) Overvalued in 2026?

Based on GuruFocus' analysis, Vimta Labs stock appears to be overvalued. The current stock price of ₹617.60 is trading 20.7% above its estimated GF Value™ of ₹511.79. GuruFocus considers Vimta Labs to be Modestly Overvalued.

Key valuation signals for BOM:524394:

  • Cyclically Adjusted Revenue per Share: ₹71.25
  • GF Value™: ₹511.79 vs. price of ₹617.60 (20.7% above fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the BOM:524394 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimta Labs Business Description

Other Exchanges VIMTALABS:India
Address Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
84GF Score

Get the complete analysis for BOM:524394

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹617.60
Price
₹511.79
GF Value